| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 5, 2016Data Add to Body of Evidence Supporting World's Smallest Pacemaker
DUBLIN and SAN FRANCISCO - May 5, 2016 - Medtronic plc (NYSE:MDT) today announced clinical results highlighting the strong safety and performance profile of the miniaturized Micra® Transcatheter...
-
May 5, 2016
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
May 4, 2016-- First quarter 2016 revenue of $55 million reflects lower year-over-year clinical trial revenue and competitive dynamics --
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
May 4, 2016Gary Ellis to Remain on Medtronic Executive Committee Until Retirement in Fiscal Year 2017
DUBLIN - May 4, 2016 - Medtronic plc (NYSE: MDT) announced today the appointment of Karen L. Parkhill as executive vice president and chief financial officer (CFO), effective June 20, 2016....
-
May 3, 2016Study Represents Longest Patient Follow-Up Data for U.S. 2-Level Cervical Disc Patients
DUBLIN and CHICAGO - May 3, 2016 - Medtronic plc (NYSE: MDT) today announced results of seven-year follow-up data demonstrating favorable clinical outcomes and patient satisfaction for the 2-level...
-
May 2, 2016Visia AF MRI(TM) SureScan® and Visia AF(TM)ICDs Treat Dangerous Heart Rhythms and Enable Physicians to Identify Patients at Increased Risk for Stroke and Heart Failure Due to AF
DUBLIN - May 2, 2016 - Medtronic plc (NYSE: MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the Visia AF MRI(TM) SureScan® and Visia AF(TM)...
-
May 2, 2016Patients with Hydrocephalus and CSF Disorders Have Greater Access to Full Body MRI Scans with StrataMR
DUBLIN - May 2, 2016 - Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) clearance of StrataMR(TM) valves and shunts, an addition to Medtronic's family of...
-
May 1, 2016Potentially Reaching More Patients at Risk for Colon Cancer
DUBLIN - March 31, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) cleared PillCam(TM) COLON 2 capsule for an expanded indication for use. The...
-
Apr 30, 2016New Data at ACC.16 First to Show Superior, Longer-Term Outcomes for Self-Expanding TAVR vs. SAVR at Three Years Results Published Simultaneously in the Journal of American College of Cardiology (JACC)
DUBLIN and CHICAGO - April 3, 2016 - Medtronic plc (NYSE: MDT) today announced new data from the High Risk Study of the CoreValve U.S. Pivotal Trial that show superior clinical outcomes for...
-
Apr 27, 2016Clinical Integrity on Display through Longest Term Data of 1,200 Endurant AAA Stent Graft Patients
DUBLIN AND LONDON - April 27, 2016 - Medtronic plc (NYSE:MDT) today reported on the ENGAGE global registry of experiences with the Endurant® AAA stent graft system from Medtronic with a reference...